Bizarre Patents
A new toilet tank assembly aquarium for housing aquatic creatures.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5187177 | Method and a pharmaceutical preparation for treating pain A method of relieving pain comprises administering, to the subject suffering from the pain, a pharmaceutically effective amount of glucagon and a spasmogenic analgesic. A ratio of 0.1-10 parts of glucagon per 10 parts of analgesic is administered. Further... | 02/16/1993 |
| 5183807 | Use of monosialoganglioside GM, to prevent the development of tolerance to the analgesic effect of morphine and related drugs The use of monosialoganglioside GM1, of its pharmacologically acceptable salts and of its internal ester derivative for the preparation of pharmaceutical compositions for preventing the development in man of tolerance to the analgesic effect of... | 02/02/1993 |
| 5180736 | Polycyclic amines useful as cerebrovascular agents A novel series of polycyclic amines, derivatives, methods of making the compounds, novel intermediates, compositions containing them, and methods for using them in the treatment and prevention of cerebrovascular disorders are disclosed.... | 01/19/1993 |
| 5175144 | Method of retarding the progression of chronic renal failure Progression of chronic renal failure can be retarded (slowed or arrested) by administering to humans suffering from such disorder an agent which suppresses the production of glucocorticoids in the human. The agents may be administered alone or in combinat... | 12/29/1992 |
| 5164398 | Ibuprofen-antitussive combinations This invention relates to pharmaceutical compositions for use in the treatment of pain and inflammation and the relief of cough and cold symptoms in a mammalian organism, said composition comprising: (i) an analgesically and anti-inflammatory effective amount ... | 11/17/1992 |
| 5130412 | Electrochemical drug release and article An electrically conducting self-doped carbazole polymer of the formula: ##STR1## wherein A is a bifunctional molecule capable of bonding to a positively charged molecule at one end and is capable of bonding to a flexible spacer group Z at another end... | 07/14/1992 |
| 5116840 | Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives Novel polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives are disclosed which are useful for treating allergic reactions, inflammation, peptic ulcers, hypertension, and hyperproliferative skin diseases and for suppressing the immune respo... | 05/26/1992 |
| 5114947 | Method for alleviating anxiety using benzobicyclic carboxamides Benzofuran--7--carboxamides with anxiolytic activity.... | 05/19/1992 |
| 5104875 | Combination preparations containing rifampicin and thioacetazon Pharmaceutical combination preparations containing rifampicin and thioacetazon and optionally isonicotinic acid hydrazide or ethambutol and the use of same for the treatment of mycobacterial infections.... | 04/14/1992 |
| 5102887 | Method for reducing emesis and nausea induced by the administration of an emesis causing agent A method for preventing or relieving nausea and emesis associated with the use of an emesis-causing agent in warm-blooded animals comprises administering to the animal both a narcotic analgesic and a quaternary derivative of noroxymorphone prior to, simul... | 04/07/1992 |
| 5086058 | Method for treating alcoholism with nalmefene A method for treating alcoholism. The alcohol-drinking response of alcoholics is extinguished by having them drink alcoholic beverages while nalmefene, an opiate antagonist, blocks the positive reinforcement effect of ethanol in the brain.... | 02/04/1992 |
| 5084460 | Methods of therapeutic treatment with N-(3-ouinuclidinyl)-2-hydroxybenzamides and thiobenzamides This invention provides 3-quinuclidinyl benzamides which in the form of pharmaceutical compositions have utility as therapeutic agents which exhibit anxiolytic antipsychotic and cognitive improving effects in warm blooded animals. Illustrative of an inven... | 01/28/1992 |
| 5075341 | Treatment for cocaine abuse Mixed opiate agonist/antagonists, particularly buprenorphine, is provided for the treatment of cocaine dependence and concurrent cocaine and opiate abuse and dependence.... | 12/24/1991 |
| 5073380 | Oral sustained release pharmaceutical formulation and process A pharmaceutical sustained release tablet or tablet layer is formed by making a wet granulation, using povidone (PVP) in water or alcohol-water as the granulating fluid which is mixed with a pharmaceutical active, hydroxyethyl cellulose, a wicking agent e... | 12/17/1991 |
| 5071853 | Polycyclic amines useful as cerebrovascular agents A novel series of polycyclic amines, derivatives, methods of making the compounds, novel intermediates, compositions containing them, and methods for using them in the treatment and prevention of cerebrovascular disorders are disclosed.... | 12/10/1991 |
| 5057322 | Method of treating mast cell disease A method of treating a patient suffering from mast cell disease comprising daily administration to such patient of from about 1 to about 150 mg of a pure narcotic antagonist, e.g., nalmefene or naltrexone. The antagonist may be administered in divided dos... | 10/15/1991 |
| 5057519 | 5-HT3 antagonists: use in reducing opiate tolerance The use of 5-HT3 antagonists and their pharmaceutically acceptable salts in reducing tolerance to opiates in particular morphine.... | 10/15/1991 |
| 5053228 | Polymeric temperature sensitive drug carrier The drug carrier of this invention provides a temperature-sensitive polymer chemically bonded to a drug. The drug carrier is capable of releasing a drug continuously in the body. The drug carrier is a liquid when administered and becomes solid in the body... | 10/01/1991 |
| 5028612 | Method for treating emotional numbness An opiate antagonist or a pharmaceutically acceptable salt thereof is used to treat emotional numbness associated with Post Traumatic Stress Disorder and other psychopathologic conditions.... | 07/02/1991 |
| 5013739 | Method of treating chronic fatigue syndrome using an opiate receptor antagonist Chronic herpes viral infections, including chronic genital herpes caused by the herpes simplex virus, Type 2, and chronic infections due to the Epstein-Barr virus, chronic fatigue syndrome, chronic inflammatory connective tissue disease, including rheumat... | 05/07/1991 |
| 5013740 | Method for treating emotional numbness and coma An opiate antagonist or a pharmaceutically acceptable salt thereof is used to treat emotional numbness associated with Post Traumatic Stress Disorder and other psychopathologic conditions. Opiate antagonist or a pharmaceutically acceptable salt thereof is... | 05/07/1991 |
| 5004613 | Oral sustained release pharmaceutical formulation and process A pharmaceutical sustained release tablet or tablet layer is formed by making a wet granulation, using povidone (PVP) in water or alcohol-water as the granulating fluid which is mixed with a pharmaceutical active, hydroxyethyl cellulose, a wicking agent e... | 04/02/1991 |
| 5002936 | Lipophilic complexes of pharmacologically active inorganic mineral acid esters of organic compounds The present invention provides a composition with the structure (L)m (E)n wherein (L)m and (E)n are bound as a complex, wherein L is a lipophilic compound; wherein E is a nonlipophilic, ionic, inorganic ester of an o... | 03/26/1991 |
| 4994466 | Method of treatment for multiple sclerosis A method of treating a patient suffering from multiple sclerosis comprising daily administration to such patient of from about 1 to about 100 mg of a pure narcotic antagonist, e.g., nalmefene or naltrexone. The antagonist may be administered in divided do... | 02/19/1991 |
| 4988705 | Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives Novel polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives are disclosed which are useful for treating allergic reactions, inflammation, peptic ulcers, hypertension, and hyperproliferative skin diseases and for suppressing the immune respo... | 01/29/1991 |
| 4987136 | Method for controlling gastrointestinal dysmotility Method for controlling gastrointestinal dysmotility in humans by administration of opioid antagonists.... | 01/22/1991 |
| 4971960 | Substituted 1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acids Indole derivatives characterized by having a 1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid nucleus bearing a substituent in position 1 and 4. The nucleus may be optionally substituted at positions 5, 6, 7 and 8. The derivatives are useful anti-infla... | 11/20/1990 |
| 4970212 | Method of treating human illnesses which compromise the ability to mount an effective immunological response A method is disclosed for treating human patients suffering from illnesses, including AIDS, which compromise their ability to mount an effective immunological response. This method comprises administering to the patient a pharmaceutically acceptable cytos... | 11/13/1990 |
| 4946848 | Method of treating pruritus with nalmefene and clonidine A method of treating a mammal suffering from pruritus, whether antigen-induced or disease-induced, comprising orally administering to the subject from about 1 to about 25 mg of the narcotic antagonist nalmefene for an initial period of 1 to 7 days, and gr... | 08/07/1990 |
| 4940586 | Skin permeation enhancer compositions using sucrose esters A method for enhancing the transdermal flux of a transdermally deliverable drug through intact skin is described in which the drug is delivered simultaneously with sucrose monolaurate or a mixture of sucrose esters of coconut fatty acids, which is predomi... | 07/10/1990 |
| 4935428 | Treating opiate dependence A pharmaceutical composition in sublingual unit dosage form for maintenance treatment of opiate addicts comprising from 2 to 8 mg buprenorphine and an amount of naltrexone sufficient to substantially attenuate the euphorigenic effect of the buprenorphine ... | 06/19/1990 |
| 4925848 | Derivative of codeine useful as an agonist and process for the preparation of it A compound of the formula: ##STR1## A process for its preparation and pharmaceutical compositions comprising the compound or a pharmaceutically acceptable salt thereof with a pharmaceutically acceptable diluent or carrier. The compound exhibits ... | 05/15/1990 |
| 4923875 | Method for treatment of mast cell-mediated dermatologic disorders A method of treating human or animal patients suffering from mast cell-mediated dermatological disorders comprising the administration to the affected skin areas of a topical composition comprising from about 0.01 to about 10% by weight of the narcotic an... | 05/08/1990 |
| 4912114 | Morphinan derivatives Compounds of formula I ##STR1## wherein X and Y each denotes hydrogen or together denote -0-, R1 denotes allyl optionally substituted by 1 to 3 alkyl groups, the substituent or substituents having in total a maximum of 3 carbon atoms, cycl... | 03/27/1990 |
| 4910152 | Method for binding opioid receptors A method of controlling weight in a mammal and diagnosing, treating, and preventing disorders associated with delta-type opioid receptors comprising administering to the mammal a receptor probe or a weight control agent for inhibiting weight gain. The rec... | 03/20/1990 |
| 4908389 | Penetration enhancement system The penetration of various drugs through living membranes, eg., skin, is improved by their use in topical compositions containing certain penetration-enhancer systems.... | 03/13/1990 |
| 4906638 | Dextromethorphan potentiator for anticonvulsant composition and method A pharmaceutical composition comprises an anti-epileptic drug that does not inhibit, enhance or otherwise modify dextromethorphan binding to the central nervous system dextromethorphan receptor and an effective amount of dextromethorphan to potentiate the... | 03/06/1990 |
| 4906637 | Traumatic and ischemic brain injury treatment with opiate-receptor antagonists The present invention involves methods of inducing opiate-receptor antagonistic activity in a patient suffering from ischemic or traumatic brain injury by administering to said patient an effective amount of an opiate-receptor antagonist having enhanced a... | 03/06/1990 |
| 4891377 | Transdermal delivery of the narcotic analgesics etorphine and analogs A process for relieving pain and novel topical compositions for transdermal delivery of a narcotic analgesic comprising the application to mammalian skin of an effective amount of a compound of the formula: ##STR1## or a pharmacologically acceptable ... | 01/02/1990 |
| 4889860 | Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists A potent, selective opioid receptor agonist or antagonist exhibiting properties useful for a longacting analgesic or opiate abuse treatment agent or appetite suppressant having the general formula: ##STR1## wherein R is methyl, cyclopropylmethyl or a... | 12/26/1989 |
